BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND JAK2, ENSG00000096968, O60674, JTK10, 3717 AND Treatment
64 results:

  • 1. Cucurbitacin B Inhibits the Malignancy of Esophageal Carcinoma through the KIF20A/JAK/STAT3 Signaling Pathway.
    Liu C; Ji J; Li C
    Am J Chin Med; 2024; 52(1):275-289. PubMed ID: 38291583
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. AKT2
    Chen J; Zhang L; Zhu Y; Zhao D; Zhang J; Zhu Y; Pang J; Xiao Y; Wu Q; Wang Y; Zhan Q
    Signal Transduct Target Ther; 2024 Jan; 9(1):21. PubMed ID: 38280862
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. IL-6/jak2-dependent G6PD phosphorylation promotes nucleotide synthesis and supports tumor growth.
    Qiu X; Ye H; Li X; Li D; Jiang L; Liu R; Zhao Z; He D
    Mol Metab; 2023 Dec; 78():101836. PubMed ID: 37949355
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer.
    Hong L; Aminu M; Li S; Lu X; Petranovic M; Saad MB; Chen P; Qin K; Varghese S; Rinsurongkawong W; Rinsurongkawong V; Spelman A; Elamin YY; Negrao MV; Skoulidis F; Gay CM; Cascone T; Gandhi SJ; Lin SH; Lee PP; Carter BW; Wu CC; Antonoff MB; Sepesi B; Lewis J; Gibbons DL; Vaporciyan AA; Le X; Jack Lee J; Roy-Chowdhuri S; Routbort MJ; Gainor JF; Heymach JV; Lou Y; Wu J; Zhang J; Vokes NI
    Nat Commun; 2023 Feb; 14(1):695. PubMed ID: 36755027
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Circ_0000052/miR-382-3p axis induces PD-L1 expression and regulates cell proliferation and immune evasion in head and neck squamous cell carcinoma.
    Zhang DJ; Fu ZM; Guo YY; Guo F; Wan YN; Guan GF
    J Cell Mol Med; 2023 Jan; 27(1):113-126. PubMed ID: 36515567
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Oridonin represses epithelial-mesenchymal transition and angiogenesis of thyroid cancer via downregulating jak2/STAT3 signaling.
    Liu W; Wang X; Wang L; Mei Y; Yun Y; Yao X; Chen Q; Zhou J; Kou B
    Int J Med Sci; 2022; 19(6):965-974. PubMed ID: 35813296
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. In Situ PD-L1 Expression in Oral Squamous Cell Carcinoma Is Induced by Heterogeneous Mechanisms among Patients.
    Kondo Y; Suzuki S; Ono S; Goto M; Miyabe S; Ogawa T; Tsuchida H; Ito H; Takahara T; Satou A; Tsuzuki T; Yoshikawa K; Ueda R; Nagao T
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456895
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian cancer.
    Weber-Lassalle K; Ernst C; Reuss A; Möllenhoff K; Baumann K; Jackisch C; Hauke J; Dietrich D; Borde J; Park-Simon TW; Hanker L; Prieske K; Schmidt S; Weber-Lassalle N; Pohl-Rescigno E; Kommoss S; Marmé F; Heitz F; Stingl JC; Schmutzler RK; Harter P; Hahnen E
    J Natl Cancer Inst; 2022 Apr; 114(4):565-570. PubMed ID: 34963005
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Naringin inhibits the proliferation and invasion of Eca109 esophageal cancer cells and promotes its apoptosis by blocking JAK/STAT signal pathway].
    Yang F; Jiang T; Zhang L; Qi Y; Yang Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Dec; 37(12):1085-1091. PubMed ID: 34906296
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma.
    Liu S; Knochelmann HM; Lomeli SH; Hong A; Richardson M; Yang Z; Lim RJ; Wang Y; Dumitras C; Krysan K; Timmers C; Romeo MJ; Krieg C; O'Quinn EC; Horton JD; Dubinett SM; Paulos CM; Neskey DM; Lo RS
    Cell Rep Med; 2021 Oct; 2(10):100411. PubMed ID: 34755131
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Curcumin inhibits proliferation and invasion of papillary thyroid carcinoma cells by inhibiting the jak2 / STAT3 pathway.
    Hu Y; Zhou N; Zhu Q
    J BUON; 2021; 26(4):1635-1641. PubMed ID: 34565029
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Brusatol inhibits laryngeal cancer cell proliferation and metastasis via abrogating jak2/STAT3 signaling mediated epithelial-mesenchymal transition.
    Zhou J; Hou J; Wang J; Wang J; Gao J; Bai Y
    Life Sci; 2021 Nov; 284():119907. PubMed ID: 34453950
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Dehydrocostus Lactone Induces Apoptosis and Cell Cycle Arrest through Regulation of jak2/STAT3/PLK1 Signaling Pathway in Human Esophageal Squamous Cell Carcinoma Cells.
    Yang G; Sheng B; Li R; Xu Q; Zhang L; Lu Z
    Anticancer Agents Med Chem; 2022; 22(9):1742-1752. PubMed ID: 34353270
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Correlation of IL-6 and jak2/STAT3 signaling pathway with prognosis of nasopharyngeal carcinoma patients.
    Zhuang M; Ding X; Song W; Chen H; Guan H; Yu Y; Zhang Z; Dong X
    Aging (Albany NY); 2021 Jun; 13(12):16667-16683. PubMed ID: 34165442
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Acylglycerol kinase promotes paclitaxel resistance in nasopharyngeal carcinoma cells by regulating FOXM1 via the jak2/STAT3 pathway.
    Zhao C; Chen HY; Zhao F; Feng HJ; Su JP
    Cytokine; 2021 Dec; 148():155595. PubMed ID: 34116927
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Phlorizin from sweet tea inhibits the progress of esophageal cancer by antagonizing the jak2/STAT3 signaling pathway.
    Jia Z; Xie Y; Wu H; Wang Z; Li A; Li Z; Yang Z; Zhang Z; Xing Z; Zhang X
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036398
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. SOX12 contributes to the activation of the jak2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
    Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
    Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Carbon Ion Therapy Inhibits Esophageal Squamous Cell Carcinoma Metastasis by Upregulating STAT3 Through the jak2/STAT3 Signaling Pathway.
    Luo H; Yang Z; Zhang Q; Shao L; Wei S; Liu R; Li Z; Geng Y; Li C; Wang X
    Front Public Health; 2020; 8():579705. PubMed ID: 33330321
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. PD1 Blockade Enhances ICAM1-Directed CAR T Therapeutic Efficacy in Advanced Thyroid cancer.
    Gray KD; McCloskey JE; Vedvyas Y; Kalloo OR; Eshaky SE; Yang Y; Shevlin E; Zaman M; Ullmann TM; Liang H; Stefanova D; Christos PJ; Scognamiglio T; Tassler AB; Zarnegar R; Fahey TJ; Jin MM; Min IM
    Clin Cancer Res; 2020 Nov; 26(22):6003-6016. PubMed ID: 32887724
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Cetuximab enhances oridonin-induced apoptosis through mitochondrial pathway and endoplasmic reticulum stress in laryngeal squamous cell carcinoma cells.
    Kang N; Cao S; Jiang B; Zhang Q; Donkor PO; Zhu Y; Qiu F; Gao X
    Toxicol In Vitro; 2020 Sep; 67():104885. PubMed ID: 32407876
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.